Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,518.9
-11.4 (-0.45%)

 

  • STI Straits Times Index
    2,518.9
    -11.4 (-0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,449.0
    12.2 (0.85%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,301.4
    -83.3 (-0.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,836.8
    -9.7 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,419.2
    148.1 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,641.6
    14.8 (0.32%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,221.7M
  • Value: 1,172.2M
  • Rise: 157
  • Fall: 140
  • Unch: 511

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Reenova Investment^0.003+0.001
Medtecs Intl0.235+0.045
Rex Intl0.144-
UG Healthcare0.455+0.085
Clearbridge0.205+0.021
Singapore-eDev0.056+0.003
ComfortDelGro1.530-
Genting Sing0.780+0.020
Singtel2.620-0.040
Golden Agri-Res0.150+0.003

World Indices

World Indices
Name Last Change
Nasdaq 9,340.2 +15.6
HSI 23,301.4 -83.3
HSCEI 9,567.4 -27.8
Jakarta 4,641.6 +14.8
Nikkei 225 21,419.2 +148.1
SSE Comp 2,836.8 -9.7
Shanghai A 2,973.3 -10.2
Shanghai B 207.0 -1.1
KOSPI 2,031.2 +1.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

DARE BIOSCIENCE INC DARE BIOSCIENCE
Updated on 26 May 2020 (End of trading day)
Last (USD): 1.040 Change: -0.010 High: 1.105 Remarks: -
Change (%): -0.95 Low: 1.035
Open 1.040 Yesterday's Close 1.05
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 373,027 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.56494 Trailing EPS (USD) e -0.60999 NAV (USD) b 0.1206
PE a - Trailing PE f - Price / NAV b 8.6235
Dividend (USD) d - Cash In Hand (USD) g 0.1894 Issued & Paid-up Shares c 26,646,200
Dividend Yield (%) d - Price / Cash In Hand g 5.491 Treasury Shares h -
Beta - 75 Daysi 0.513 R-Squared - 75 Days(%)i 17.10 Market Cap (M) 27.712
Beta - 500 Daysi 0.599 R-Squared - 500 Days (%)i 1.41 Enterprise Value (M) 23.353
Piotroski F Score 0 Exchange Code DARE Par Value ( $ ) n.a.
52 Weeks Volatility (%) 86.93 Free Float (%) 82.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 20 Jul 2017.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference DARE BIOSCIENCE INC NASDAQ 27.712 - - 8.6235 -
Industry Pharmaceuticals: Major NASDAQ 1,470.647 114.250 1786.655 2.3772 0.010
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 118,538.506 37.744 37.744 1.7919 -
Local Peer REPLIGEN CORP NASDAQ 6,974.965 325.768 300.995 6.5201 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 5,254.642 7.510 7.510 0.9708 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 5,243.543 - - 22.9329 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 4,056.392 - - 3.1289 -
Local Peer ALLAKOS INC NASDAQ 3,537.507 - - 7.3999 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 2,916.989 - - 10.1280 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 2,562.915 - - 9.8956 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,638.020 - - 6.9111 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 2,229.159 - - 5.7909 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 2,258.669 - - 6.8145 -
Local Peer IGM BIOSCIENCES INC NASDAQ 1,916.826 - - 8.5568 -
Other Local Peers OPKO HEALTH INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ATHENEX INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), PETIQ INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PROVENTION BIO INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AC IMMUNE SA (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), DURECT CORP (NASDAQ), BEYONDSPRING INC (NASDAQ), IMARA INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), EVOLUS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), HARROW HEALTH INC (NASDAQ), MUSTANG BIO INC (NASDAQ), IMMUNIC INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MEDIWOUND LTD (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), NOVAN INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), AKORN INC (NASDAQ), TELIGENT INC NEW (NASDAQ), PROPHASE LABS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 380,856.330 25.191 22.187 6.2136 2.592
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 209,823.453 29.770 21.024 - 2.166
Global Peer PFIZER INC NYSE 208,250.577 12.798 13.189 3.2034 3.880
Global Peer MERCK & CO INC NYSE 195,011.966 19.812 19.219 7.4418 2.942
Global Peer ABBVIE INC NYSE 159,861.861 20.385 19.052 -21.5591 4.061
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 139,386.133 103.978 187.414 - 2.579
Global Peer ELI LILLY AND COMPANY NYSE 141,603.342 30.532 25.591 45.9932 1.745
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 136,485.461 39.688 143.067 2.7346 2.742
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 114,916.304 19.680 27.011 - 1.794
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 102,222.190 17.250 21.194 - -
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), WUXI APPTEC (HKEx), SINOPHARM (HKEx), INNOVENT BIO-B (HKEx), CANSINOBIO-B (HKEx), SH PHARMA (HKEx), JUNSHI BIO-B (HKEx), BAIYUNSHAN PH (HKEx), CHINARES PHARMA (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CMS (HKEx), HENLIUS-B (HKEx), AKESO-B (HKEx), INNOCARE-B (HKEx), ADC THERAPEUTICS SA (NYSE), CHINAGRANDPHARM (HKEx), TRAD CHI MED (HKEx), SSY GROUP (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), CSTONE PHARMA-B (HKEx), HUA MEDICINE-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), Kimia Farma Tbk. (IDX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARM (HKEx), TOT BIOPHARM-B (HKEx), LANNETT CO INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), DAWNRAYS PHARMA (HKEx), PYC THERAPEUTICS LIMITED (ASX), BIOMX INC (NYSE American), PHARMA (Bursa), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), IX Biopharma (SGX), NC HEALTHCARE (HKEx), PAK FAH YEOW (HKEx), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), KOTRA (Bursa), Merck Tbk. (IDX), Phapros Tbk. (IDX), PALLA PHARMA LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), NOVA (Bursa), ONCOSIL MEDICAL LIMITED (ASX), Hyphens Pharma (SGX), IP (SET), NEP INTERLONG (HKEx), WAI YUEN TONG (HKEx), TBG DIAGNOSTICS LTD (ASX), SANAI HEALTH GP (HKEx), TIMBER PHARMACEUTICALS INC (NYSE American), PURAPHARM (HKEx), JCT (SET), MEDLAB CLINICAL LIMITED (ASX), ANNOVIS BIO INC (NYSE American), NOXOPHARM LTD (ASX), BIOHLDG (Bursa), AGEX THERAPEUTICS INC (NYSE American), INVION LTD (ASX), PHARMAXIS (ASX), RACE ONCOLOGY LTD (ASX), EXTRAWELL PHAR (HKEx), EXOPHARM LTD (ASX), ACRUX (ASX), SINOLIFE UTD (HKEx), CELLMID LIMITED (ASX), TALI DIGITAL LIMITED (ASX), PASHUN INT'L (HKEx), CRESO PHARMA LTD (ASX), SUNZEN (Bursa), IMMURON LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), FIJI KAVA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.010
-0.95 %
10 Days --0.010
-0.95 %
20 Days --0.050
-4.59 %
Medium Term Return 3 Months --0.150
-12.61 %
6 Months -+0.245
+30.82 %
1 Year -+0.167
+19.13 %
Long Term Return 2 Years --0.080
-7.14 %
Annualised Return Annualised --
-3.64 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.690 - 2.220 Change From 1 Year Low +0.350 % Change From 1 Year Low (%) +50.68
Change From 1 Year High -1.180 % Change From 1 Year High (%) -53.15
2 Years Range 0.600 - 3.250 Change From 2 Years Low +0.440 % Change From 2 Years Low (%) +73.33
Change From 2 Years High -2.210 % Change From 2 Years High (%) -68.00
5 Years Range 0.600 - 6.623 Change From 5 Years Low +0.440 % Change From 5 Years Low (%) +73.33
Change From 5 Years High -5.583 % Change From 5 Years High (%) -84.30
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
26 May 2020 1.040 1.105 1.035 1.040 373,027 -
22 May 2020 1.030 1.050 1.030 1.050 138,892 -
21 May 2020 1.050 1.070 1.030 1.030 213,507 -
20 May 2020 1.040 1.080 1.040 1.050 169,648 -
19 May 2020 1.040 1.070 1.040 1.070 136,141 -
18 May 2020 1.020 1.050 1.000 1.050 200,342 -
15 May 2020 1.050 1.050 1.010 1.020 341,341 -
14 May 2020 1.080 1.090 1.040 1.050 434,338 -
13 May 2020 1.110 1.150 1.040 1.050 362,019 -
12 May 2020 1.110 1.130 1.080 1.090 345,131 -
11 May 2020 1.120 1.140 1.080 1.080 364,026 -
08 May 2020 1.100 1.140 1.090 1.100 382,958 -
07 May 2020 1.050 1.090 1.030 1.090 122,871 -
06 May 2020 1.070 1.080 1.040 1.040 359,898 -
05 May 2020 1.080 1.100 1.060 1.080 396,487 -
04 May 2020 1.100 1.100 1.050 1.100 325,315 -
01 May 2020 1.080 1.120 1.050 1.090 532,430 -
30 Apr 2020 1.180 1.180 1.070 1.110 1,748,239 -
29 Apr 2020 1.130 1.150 1.070 1.090 715,931 -
28 Apr 2020 1.240 1.270 1.070 1.075 3,513,092 -
27 Apr 2020 1.070 1.080 1.030 1.050 585,011 -
24 Apr 2020 1.060 1.060 1.020 1.035 92,166 -
Summary
Current 2 Weeks
(12 May 2020 to 26 May 2020)
1.110 1.150 1.000 1.040 2,714,386 -
Previous 2 Weeks
(28 Apr 2020 to 11 May 2020)
1.240 1.270 1.000 1.080 8,461,247 -
4 Weeks from
(30 Mar 2020 to 27 Apr 2020)
0.900 1.150 0.853 1.050 3,411,879 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.